Chang-tai Zhu, Zhong-yi Hu, Chun-lei Dong, Chang-song Zhang, Mei-zhen Wan, Yang Ling
Department of Oncological Medicine, Changzhou Tumor Hospital Soochow University, Changzhou - 213 001, Shanghai, P R China.
Indian J Med Microbiol. 2011 Jul-Sep;29(3):288-92. doi: 10.4103/0255-0857.83915.
To develop Taqman fluorescence quantitative polymerase chain reaction (PCR) method for investigating the characteristics of the distributions of Ureaplasma urealyticum (UU) biovars and to explore the relationship between UU biovars and antimicrobial resistance.
By the method of culture, Ureaplasma species were detected. Taqman fluorescence quantitative PCR for detecting UU biovars were developed and UU clinical isolates were detected to distinguish biovars. The broth micro-dilution susceptibility testing methods were used to determine UU susceptibility.
By Taqman PCR method, UU biovars was successfully detected. Of 126 samples, biovar 1 was found in 73 (57.94%). There was a statistical difference between genital-urinary tract infection group and asymptomatic group (P<0.05). In the region, UU biovar 1 to 9 kinds of agents kept higher susceptibility rates, but biovar 2 maintained higher susceptibility rates only to tetracyclines. Compared with biovar 1, UU biovar 2 resistance rates to 7 kinds of agents were higher (P<0.05).
(1) Our new established Taqman PCR method is a useful tool for screening UU biovars. (2) UU biovar 1 predominated in asymptomatic population; whereas in genital-urinary tract infection population UU biovar 2 had a higher proportion. (3) The characteristics of drug resistance were different between UU biovars. Overall, both two biovars remained higher susceptibility rates to tetracyclines. A majority of biovor 1 strains were sensitive to macrolides and quinolones; while only a small number of biovar 2 strains kept sensitive to roxithromycin and quinolones, a large proportion of biovar 2 strains were found in intermediate ranges.
建立Taqman荧光定量聚合酶链反应(PCR)方法,以研究解脲脲原体(UU)生物变种的分布特征,并探讨UU生物变种与抗菌药物耐药性之间的关系。
采用培养法检测脲原体属。建立用于检测UU生物变种的Taqman荧光定量PCR方法,并检测UU临床分离株以区分生物变种。采用肉汤微量稀释药敏试验方法测定UU的药敏情况。
通过Taqman PCR方法成功检测到UU生物变种。在126份样本中,发现生物变种1有73份(57.94%)。泌尿生殖道感染组与无症状组之间存在统计学差异(P<0.05)。在该地区,UU生物变种1对9种药物保持较高的敏感率,但生物变种2仅对四环素类保持较高的敏感率。与生物变种1相比,UU生物变种2对7种药物的耐药率更高(P<0.05)。
(1)我们新建立的Taqman PCR方法是筛选UU生物变种的有用工具。(2)UU生物变种1在无症状人群中占主导;而在泌尿生殖道感染人群中,UU生物变种2的比例较高。(3)UU生物变种之间的耐药特征不同。总体而言,两种生物变种对四环素类均保持较高的敏感率。大多数生物变种1菌株对大环内酯类和喹诺酮类敏感;而只有少数生物变种2菌株对罗红霉素和喹诺酮类敏感,大部分生物变种2菌株处于中介范围。